资讯

Pharmabiz22 小时
Theriva Biologics presents data from phase 1b/2a trial of ribaxamase in allogeneic ...
Rockville, Maryland Saturday, April 12, 2025, 18:00 Hrs [IST] ...
Pharmabiz23 小时
Adaptin Bio completes alternative public offering and closes $7.7 million private placement
Adaptin Bio completes alternative public offering and closes $7.7 million private placement: Charlotte, NC Saturday, April 12, 2025, 17:00 Hrs [IST] Adaptin Bio, Inc, a biotechnol ...